蛋白酶体抑制剂硼替佐米逆转结肠癌获得性TRAIL耐药的研究
Overcoming Acquired TRAIL Resistance in Human Colon Cancer by Proteasome Inhibitor Bortezomib
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|